Left ventricular hypertrophy: a new approach for fibrosis inhibition.
Muiesan
Maria Lorenza
ML
D000818:Animals; D003094:Collagen / Q000096:biosynthesis; D005355:Fibrosis; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy / Q000378:metabolism / Q000517:prevention & control*; D051381:Rats; D044140:Receptor, Angiotensin, Type 1; D011945:Receptors, Angiotensin / Q000378:metabolism; D016212:Transforming Growth Factor beta / Q000378:metabolism; D053773:Transforming Growth Factor beta1; D062367:ortho-Aminobenzoates / Q000627:therapeutic use
D044140:Receptor, Angiotensin, Type 1; D011945:Receptors, Angiotensin; C508960:TGFB1 protein, human; C508962:Tgfb1 protein, rat; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1; D062367:ortho-Aminobenzoates; D003094:Collagen; C012293:tranilast